Results
SPARC FY26 Net Profit Surges ₹15,532 Crores on PRV Sale
SPARC reported a dramatic turnaround with FY26 net profit of ₹15,532 crores versus FY25 loss of ₹342.5 crores, driven by ₹18,400 crores PRV income from FDA approval.
The company received FDA approval
